Theme Section: ESFH Proceedings| Volume 20, ISSUE 1, P37-42, February 1999

Cost containment in platelet transfusion: clinical and technical aspects

      Presently there is considerable emphasis placed on cost containment of in the health care system. In blood transfusion (BT) there are several ways to meet demand. In this field, advances in medical technology have been of paramount importance. Autologous BT is the simplest way to deal with the problem, a second method is the use of new drugs which can be employed along with autologous transfusion systems to supplement allogeneic BT. The third way to reduce costs is related to the Multicomponent Collection System (MCS). First described in 1987 for autologous transfusion using the name of preoperative sequestration of PRBC, plasma and platelets from a patient as the beginning of the operative session, MCS has expanded to include the collection of multiple blood components from the same donor during a single donation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Valbonesi M, Capra C, Frisoni R et al. Plateletapheresis concentrates produced in 30 min along with plasma and packed red cells; preliminary results. J Clin Apheresis 1988;4:152–154

      2. Valbonesi M, Florio G, Frisoni R. Preparation and storage in plasma-Lyte of platelets collected with cell separators CS 3000 plus equipped with the PLT 30 separation and TNX 6 collection chamber. Int J Art Organs 1995:39–44

      3. Bordin JO, Bardossy L, Blajchmann MA. Experimental animal model of refractoriness to donor platelets: the effect of plasma removal and the extent of cell reduction on allogeneic alloimmunization. Transfusion 1993;33:798–801

      4. Triulzi DO, Vanek K, Ryan DH et al. A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion 1992;32:517–523

      5. Ciavarella D (Should). Apheresis supplement whole blood collection? Transfusion Sci 1992;13:201–205

      6. Trenchard PM, Dixon R. Blood product costing: relationship to price and clinical efficacy. Transfusion Med 1995;5:231–240